This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ouarzane-Amara, M.
Right arrow Articles by Desportes-Livage, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ouarzane-Amara, M.
Right arrow Articles by Desportes-Livage, I.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2001, p. 3409-3415, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3409-3415.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

In Vitro Activities of Two Antimitotic Compounds, Pancratistatin and 7-Deoxynarciclasine, against Encephalitozoon intestinalis, a Microsporidium Causing Infections in Humans

Meryem Ouarzane-Amara,1 Jean-François Franetich,1 Dominique Mazier,1 George R. Pettit,2 Laurent Meijer,3 Christian Doerig,1 and Isabelle Desportes-Livage1,*

INSERM U511, Immunobiologie Cellulaire et Moléculaire des Infections Parasitaires, CHU Pitié-Salpêtrière, 75643 Paris Cedex 13,1 and Centre National de la Recherche Scientifique, Station Biologique, 29682 Roscoff Cedex,3 France, and Cancer Research Institute, Arizona State University, Tempe, Arizona 85287-16042

Received 9 April 2001/Returned for modification 4 June 2001/Accepted 31 August 2001

The antiparasitic effect of a collection of compounds with antimitotic activity has been tested on a mammalian cell line infected with Encephalitozoon intestinalis, a microsporidian causing intestinal and systemic infection in immunocompromised patients. The antiparasitic effect was evaluated by counting the number of parasitophorous vacuoles detected by immunofluorescence. Out of 526 compounds tested, 2 (pancratistatin and 7-deoxynarciclasine) inhibited the infection without affecting the host cell. The 50% inhibitory concentrations (IC50s) of pancratistatin and 7-deoxynarciclasine for E. intestinalis were 0.18 µM and 0.2 µM, respectively, approximately eightfold lower than the IC50s of these same compounds against the host cells. Electron microscopy confirmed the gradual decrease in the number of parasitophorous vacuoles and showed that of the two life cycle phases, sporogony was more sensitive to the inhibitors than merogony. Furthermore, the persistence of meronts in some cells apparently devoid of sporonts and spores indicated that the inhibitors block development rather than entry of the parasite into the host cell. The occurrence of binucleate sporoblasts and spores suggests that these inhibitors blocked a specific phase of cell division.


* Corresponding author. Mailing address: INSERM Unit 511, CHU Pitié-Salpêtrière, 91 Bd de l'hôpital, 75643 Paris Cedex 13, France. Phone: (33) 1 40 77 81 05. Fax: (33) 1 45 83 88 58. E-mail: desporte{at}ext.jussieu.fr.


Antimicrobial Agents and Chemotherapy, December 2001, p. 3409-3415, Vol. 45, No. 12
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.12.3409-3415.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.